6-fluoro-1-[5-[(5-fluoro-3-oxo-2-benzofuran-1-ylidene)methyl]-3-pyridinyl]-3-hydroxy-3-methylindol-2-one
C23H14F2N2O4 — CID 166492315
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-fluoro-1-[5-[(5-fluoro-3-oxo-2-benzofuran-1-ylidene)methyl]-3-pyridinyl]-3-hydroxy-3-methylindol-2-one
6-fluoro-1-[5-[(5-fluoro-3-oxo-2-benzofuran-1-ylidene)methyl]-3-pyridinyl]-3-hydroxy-3-methylindol-2-one (PubChem CID 166492315) has the molecular formula C23H14F2N2O4 and a molecular weight of 420.37 g/mol. Its IUPAC name is 6-fluoro-1-[5-[(5-fluoro-3-oxo-2-benzofuran-1-ylidene)methyl]-3-pyridinyl]-3-hydroxy-3-methylindol-2-one.
Molecular Properties
| Compound Name | 6-fluoro-1-[5-[(5-fluoro-3-oxo-2-benzofuran-1-ylidene)methyl]-3-pyridinyl]-3-hydroxy-3-methylindol-2-one |
|---|---|
| PubChem CID | 166492315 |
| Molecular Formula | C23H14F2N2O4 |
| Molecular Weight | 420.37 g/mol |
| Exact Mass | 420.09 |
| IUPAC Name | 6-fluoro-1-[5-[(5-fluoro-3-oxo-2-benzofuran-1-ylidene)methyl]-3-pyridinyl]-3-hydroxy-3-methylindol-2-one |
| SMILES | CC1(O)C(=O)N(c2cncc(C=C3OC(=O)c4cc(F)ccc43)c2)c2cc(F)ccc21 |
| InChI | InChI=1S/C23H14F2N2O4/c1-23(30)18-5-3-14(25)9-19(18)27(22(23)29)15-6-12(10-26-11-15)7-20-16-4-2-13(24)8-17(16)21(28)31-20/h2-11,30H,1H3 |
| InChIKey | YSMYEGMIETWKKW-UHFFFAOYSA-N |
| XLogP | 3.91 |
| TPSA | 79.73 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 420.37 |
| LogP ≤ 5 | 3.91 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 166492315 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.